[1]Li L,Redding S,Dongari-Bagtzoglou A.Candida glabrata:an emerging oral opportunistic pathogen[J].J Dent Res,2007,86 (3):204-215.[2]Dodgson AR, Pujol C, Denning DW, et al.Multilocus sequence typing of Candida glabrata reveals geographically enriched clades[J]. J Clin Microbiol, 2003, 41(12): 5709-5717.[3]Pfaller MA,Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem[J]. Clin Microbiol Rev, 2007,20(1):133-163.[4]Richardson M, Lass-Flrl C.Changing epidemiology of systemic fungal infections[J].Clin Microbiol Infect,2008 ,14(Suppl 4):5-24.[5]Bodey GP,Mardani M,Hanna HA,et al.The epidemi-ology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer[J]. Am J Med,2002,112(5): 380-385.[6]Lin CY,Chen YC, Lo HJ,et al. Assessment of Candida glabrata strain relatedness by pulsed-field gel electrophoresis and multilocus sequence typing[J]. J Clin Microbiol,2007 ,45(8): 2452-2459. [7]Lott TJ,Frade JP,Lockhart SR. Multilocus sequence type analysis reveals both clonality and recombination in populations of Candida glabrata bloodstream isolates from U.S. surveillance studies[J]. Eukaryot Cell, 2010,9(4):619-625.[8]Wong-Beringera A, Hindler J, Brankovic L, et al. Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients[J]. Diagn Microbiol Infect Dis, 2001, 39(1):25-31.[9]Hazen KC, Baron EJ,Colombo AL, et al.Comparison of susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion[J].J Clin Microbiol,2003,41(12):5623-5632.[10]Pfaller MA, Diekema DJ, Gibbs DL, et al.Results from the ARTEMIS DISK global antifungal surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing[J].J Clin Microbiol, 2007, 45(6):1735-1745.[11]张军民,席丽艳,鲁长明,等.医院分离深部真菌菌株流行病学调查和药敏试验研究[J].中华检验医学杂志,2007,30(1):27-30.[12]Alexander BD, Byrne TC, Smith KL, et al.Compara-tive evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents[J].J Clin Microbiol, 2007,45(3):698-706.